Madi Lama, Ahmed Elhada Arwa Hassan, Alrawashdeh Haneen, Ahmed Afif
Department of Pharmacy, Hamad Bin Khalifa Medical City, Doha, Qatar.
J Res Pharm Pract. 2019 Apr-Jun;8(2):101-104. doi: 10.4103/jrpp.JRPP_18_79.
Proton pump inhibitors (PPIs) are still widely used despite increasing reports of their adverse events. This drug use evaluation study was conducted to assess the prescribing pattern of PPIs for patients admitted to the Qatar Rehabilitation Institute (QRI).
An observational, retrospective, patients' chart-based study included all patients who received a PPI in QRI between April 1, 2017, and October 1, 2017. A standardized tool was prepared and reviewed by the involved clinical pharmacists to collect appropriate data for the evaluation. Statistical analysis was performed using the 25 Version of the Statistical Package of the Social Sciences (SPSS).
A total of 119 patients received PPIs during the audit period, of which esomeprazole was the most frequently prescribed (34%). Majority of the patients (94%) were started on PPI without further investigations for confirming the indication, and the indication was not documented in 78% of the participants. Nonsteroidal anti-inflammatory drugs were the most commonly co-prescribed medications with PPIs (59%). Pantoprazole was co-prescribed with clopidogrel in 42% of the patients.
This drug utilization study shows the need for a proper prescribing practice considering a clear indication and recommendations about the duration of therapy and the need for reassessment in QRI.
尽管质子泵抑制剂(PPIs)不良事件的报道日益增多,但它们仍被广泛使用。本药物使用评估研究旨在评估卡塔尔康复研究所(QRI)收治患者的PPIs处方模式。
一项基于患者病历的观察性回顾性研究纳入了2017年4月1日至2017年10月1日期间在QRI接受PPI治疗的所有患者。由参与的临床药师编制并审查了一个标准化工具,以收集用于评估的适当数据。使用社会科学统计软件包(SPSS)第25版进行统计分析。
在审核期间共有119名患者接受了PPIs治疗,其中埃索美拉唑的处方频率最高(34%)。大多数患者(94%)在未进行进一步检查以确认适应症的情况下开始使用PPI,78%的参与者未记录适应症。非甾体抗炎药是与PPIs最常联合使用的药物(59%)。42%的患者泮托拉唑与氯吡格雷联合使用。
本药物利用研究表明,在QRI需要考虑明确的适应症、关于治疗持续时间的建议以及重新评估的必要性,以进行适当的处方实践。